subscribeSubscribe
BioMarin`s Biologic Palynziq (pegvaliase) Receives Approval in the U.S.

BioMarin`s Biologic Palynziq (pegvaliase) Receives Approval in the U.S.
FDA
09 Dec 2023
Share Share
Biomarin Pharm`s Biological Palynziq (pegvaliase-pqpz) Receives Approval In US

Biomarin Pharm`s Biological Palynziq (pegvaliase-pqpz) Receives Approval In US
FDA
25 Nov 2020
Share Share
Biomarin Pharm`s Biological Pegvaliase-Pqpz Receives Approval In US

Biomarin Pharm`s Biological Pegvaliase-Pqpz Receives Approval In US
FDA
08 Oct 2020
Share Share
BioMarin, Pioneer in Rare Disease (PKU), Receives FDA Approval Label Expansion

BioMarin, Pioneer in Rare Disease (PKU), Receives FDA Approval Label Expansion
PRNEWSWIRE
07 Oct 2020
Share Share
EU nod for BioMarin’s second PKU therapy Palynziq

EU nod for BioMarin’s second PKU therapy Palynziq
Andrew McConaghie PMLIVE
07 May 2019
Share Share
Dupixent® (dupilumab) Approved for Severe Asthma by European Commission

Dupixent® (dupilumab) Approved for Severe Asthma by European Commission
PRESS RELEASE
07 May 2019
Share Share
EU nod for BioMarin’s second PKU therapy Palynziq

EU nod for BioMarin’s second PKU therapy Palynziq
Andrew McConaghie PMLIVE
07 May 2019
Share Share
European Commission Approves Palynziq® (pegvaliase injection)

European Commission Approves Palynziq® (pegvaliase injection)
PR NEWSWIRE
06 May 2019
Share Share
BioMarin Receives Positive CHMP Opinion in Europe for Palynziq®

BioMarin Receives Positive CHMP Opinion in Europe for Palynziq®
PR NEWSWIRE
01 Mar 2019
Share Share
Palynziq (pegvaliase-pqpz) for the Treatment of Phenylketonuria

Palynziq (pegvaliase-pqpz) for the Treatment of Phenylketonuria
DRUG DEVELOPMENT TECH
28 Jul 2018
Share Share